Third Generation CAR T Cell Study Supports Use Of BioOra’s Automated Manufacture For Phase 2 Trial

Tuesday, 12 December 2023, 12:15 pm | Bio Ora

BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego. More >>